This page shows the latest STING news and features for those working in and with pharma, biotech and healthcare.
started working on STING drugs with potential in auto-immune and inflammatory diseases. ... Eli Lilly, for example, paid $12m upfront in a $620 million deal with Aduro Biotech at the end of 2018 for STING inhibitors, focusing on autoimmune diseases.
Novartis paid $200m upfront for rights to Aduro’s STING programme in 2015. ... pipeline. Meanwhile, Mavupharma isn’t the only company trying to develop small-molecule STING agonists.
BMS’ interest was mainly on IFM’s STING and NLRP3 agonists and their potential in boosting immune responses to tumours.
salve its sting. .
STING ‘has not stung’. Merck would be an obvious choice for that role, and the analysts also suggest that a deal for SD-101 could be more likely given a lacklustre ... also that the STING agonists were speculated to be more potent based on biology
Looking at some of the new mechanisms on show, Merck/MSD will also have the first clinical results for its STING activator MK-1454, Adaptimmune will have first-in-human results
More from news
Approximately 2 fully matching, plus 18 partially matching documents found.
Among the plethora in the pipeline, Aurigene and BMS are looking at PD-1 inhibitors that can be dosed orally, Novartis, iTeos and Aduro are developing STING agonists that can
It’s like deconstructing a joke; by the end, the punchline loses its sting.
825. Aduro / Novartis. Licence and collaboration. Preclinical cancer immunotherapies targeting the STING (Stimulator of Interferon Genes) pathway.
One such example is Novartis which has CAR-T and checkpoint inhibitor programmes and has now added Aduro's STING (Stimulator of Interferon Genes) technology as an additional string to its ... bow. Aduro has a number of preclinical small molecule cyclic
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
STING - brand / diseases modules. PRECIS - clinical study modules.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...